FDA — authorised 1 October 1976
- Application: ANDA062008
- Marketing authorisation holder: LILLY
- Local brand name: NEBCIN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Nebcin on 1 October 1976
Yes. FDA authorised it on 1 October 1976; FDA authorised it on 29 April 1987.
LILLY holds the US marketing authorisation.